{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:54:05Z","timestamp":1791820445616,"version":"4.3.4"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Scientific Foundation of China","doi-asserted-by":"crossref","award":["81901586"],"award-info":[{"award-number":["81901586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Scientific Foundation of China","doi-asserted-by":"crossref","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["2019CR206"],"award-info":[{"award-number":["2019CR206"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Great advancements have been made in understanding the pathogenesis of SS, but there remain unmet needs for effective and targeted treatments. Glandular and extraglandular dysfunction in SS is associated with autoimmune lymphocytic infiltration that invades the epithelial structures of affected organs. Regulatory T (Treg) cells are a subset of CD4+ T lymphocytes that maintain self-tolerance during physiological conditions. Besides inhibiting excessive inflammation and autoimmune response by targeting various immune cell subsets and tissues, Treg cells have also been shown to promote tissue repair and regeneration in pathogenic milieus. The changes of quantity and function of Treg cells in various autoimmune and chronic inflammatory disorders have been reported, owing to their effects on immune regulation. Here we summarize the recent findings from murine models and clinical data about the dysfunction of Treg cells in SS pathogenesis and discuss the therapeutic strategies of direct or indirect targeting of Treg cells in SS. Understanding the current knowledge of Treg cells in the development of SS will be important to elucidate disease pathogenesis and may guide research for successful therapeutic intervention in this disease.<\/jats:p>","DOI":"10.1093\/rheumatology\/kead070","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T12:39:13Z","timestamp":1676464753000},"page":"2963-2970","source":"Crossref","is-referenced-by-count":13,"title":["Regulatory T cells: a new therapeutic link for Sj\u00f6gren syndrome?"],"prefix":"10.1093","volume":"62","author":[{"given":"Bingxia","family":"Ming","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3534-7480","authenticated-orcid":false,"given":"Jixin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-1125","authenticated-orcid":false,"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"2023090115160836400_kead070-B1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","article-title":"Current and future therapies for primary Sjogren syndrome","volume":"17","author":"Seror","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2023090115160836400_kead070-B2","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/rheumatology\/key330","article-title":"Genetics and epigenetics in primary Sjogren's syndrome","volume":"60","author":"Imgenberg-Kreuz","year":"2021","journal-title":"Rheumatology"},{"key":"2023090115160836400_kead070-B3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sjogren Syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"key":"2023090115160836400_kead070-B4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","article-title":"Insight into pathogenesis of Sjogren's syndrome: dissection on autoimmune infiltrates and epithelial cells","volume":"182","author":"Goules","year":"2017","journal-title":"Clin Immunol"},{"key":"2023090115160836400_kead070-B6","doi-asserted-by":"crossref","first-page":"243723","DOI":"10.1155\/2015\/243723","article-title":"T regulatory and T helper 17 cells in primary Sjogren's syndrome: facts and perspectives","volume":"2015","author":"Alunno","year":"2015","journal-title":"Mediators Inflamm"},{"key":"2023090115160836400_kead070-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","volume":"87","author":"Stadhouders","year":"2018","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","article-title":"Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjogren's syndrome with ectopic germinal centres and MALT lymphoma","volume":"79","author":"Pontarini","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023090115160836400_kead070-B9","doi-asserted-by":"crossref","first-page":"925135","DOI":"10.1155\/2012\/925135","article-title":"CD4(+)T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"2023090115160836400_kead070-B10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"2023090115160836400_kead070-B11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","article-title":"Interleukin-2 and regulatory T cells in rheumatic diseases","volume":"17","author":"Kolios","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2023090115160836400_kead070-B12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/08830185.2013.863303","article-title":"Forkhead box P3: the peacekeeper of the immune system","volume":"33","author":"Passerini","year":"2014","journal-title":"Int Rev Immunol"},{"key":"2023090115160836400_kead070-B13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"2023090115160836400_kead070-B14","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.4049\/jimmunol.174.5.2957","article-title":"CD4+CD25+ regulatory T cells control innate immune reactivity after injury","volume":"174","author":"Murphy","year":"2005","journal-title":"J Immunol"},{"key":"2023090115160836400_kead070-B15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypical and functional specialization of FOXP3+ regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2023090115160836400_kead070-B16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/eji.201344280","article-title":"Regulatory T cells in systemic lupus erythematosus","volume":"45","author":"Ohl","year":"2015","journal-title":"Eur J Immunol"},{"key":"2023090115160836400_kead070-B17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"2023090115160836400_kead070-B18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"2023090115160836400_kead070-B19","doi-asserted-by":"crossref","first-page":"eaat1482","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Revisiting IL-2: biology and therapeutic prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci Immunol"},{"key":"2023090115160836400_kead070-B20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2023090115160836400_kead070-B21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fimmu.2018.00585","article-title":"Regulatory T-Cells: potential regulator of tissue repair and regeneration","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"2023090115160836400_kead070-B22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"2023090115160836400_kead070-B23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol"},{"key":"2023090115160836400_kead070-B24","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1096\/fj.11-193672","article-title":"Naturally occurring regulatory T cells: markers, mechanisms, and manipulation","volume":"26","author":"Schmetterer","year":"2012","journal-title":"FASEB J"},{"key":"2023090115160836400_kead070-B25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature16169","article-title":"Immune homeostasis enforced by co-localized effector and regulatory T cells","volume":"528","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"2023090115160836400_kead070-B26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"2023090115160836400_kead070-B27","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1111\/all.15449","article-title":"Regulatory T cells and immunoglobulin E: a new therapeutic link for autoimmunity?","volume":"77","author":"Palomares","year":"2022","journal-title":"Allergy"},{"key":"2023090115160836400_kead070-B28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.33320","article-title":"Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease","volume":"64","author":"Tanaka","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023090115160836400_kead070-B29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2023090115160836400_kead070-B30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08916930802282651","article-title":"Quantification and molecular characterization of regulatory T cells in connective tissue diseases","volume":"42","author":"Banica","year":"2009","journal-title":"Autoimmunity"},{"key":"2023090115160836400_kead070-B31","first-page":"2438","article-title":"T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjogren's syndrome","volume":"34","author":"Li","year":"2007","journal-title":"J Rheumatol"},{"key":"2023090115160836400_kead070-B32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203307085248","article-title":"Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome","volume":"17","author":"Liu","year":"2008","journal-title":"Lupus"},{"key":"2023090115160836400_kead070-B33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2249.2009.03966.x","article-title":"Cells with regulatory function of the innate and adaptive immune system in primary Sjogren's syndrome","volume":"157","author":"Szodoray","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2023090115160836400_kead070-B34","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/annrheumdis-2018-213036","article-title":"Short-term and low-dose IL-2 therapy restores the Th17\/Treg balance in the peripheral blood of patients with primary Sjogren's syndrome","volume":"77","author":"Miao","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023090115160836400_kead070-B35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13075-022-02811-z","article-title":"Circulating Th2 cell reduction and Th1\/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease","volume":"24","author":"Shi","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2023090115160836400_kead070-B36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/biom10111539","article-title":"T cells subsets in the immunopathology and treatment of Sjogren's syndrome","volume":"10","author":"R\u00edos-R\u00edos","year":"2020","journal-title":"Biomolecules"},{"key":"2023090115160836400_kead070-B37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2005.01.015","article-title":"CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome","volume":"24","author":"Gottenberg","year":"2005","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39629","article-title":"Association of increased treg cell levels with elevated indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sjogren's syndrome","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023090115160836400_kead070-B39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/14397595.2016.1226470","article-title":"Elevated level of circulating CD4(+)Helios(+)FoxP3(+) cells in primary Sjogren's syndrome patients","volume":"27","author":"Liu","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2023090115160836400_kead070-B40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4081\/reumatismo.2012.293","article-title":"Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjogren's syndrome: correlation with disease activity","volume":"64","author":"Alunno","year":"2012","journal-title":"Reumatismo"},{"key":"2023090115160836400_kead070-B41","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/rheumatology\/ket179","article-title":"Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome","volume":"52","author":"Alunno","year":"2013","journal-title":"Rheumatology"},{"key":"2023090115160836400_kead070-B42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2353\/ajpath.2008.080246","article-title":"Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors","volume":"173","author":"Christodoulou","year":"2008","journal-title":"Am J Pathol"},{"key":"2023090115160836400_kead070-B43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0961203309348234","article-title":"The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome","volume":"19","author":"Sarigul","year":"2010","journal-title":"Lupus"},{"key":"2023090115160836400_kead070-B44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/sji.12224","article-title":"Differential cytokine expression and regulatory cells in patients with primary and secondary Sjogren's syndrome","volume":"80","author":"Furuzawa-Carballeda","year":"2014","journal-title":"Scand J Immunol"},{"key":"2023090115160836400_kead070-B45","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","article-title":"Global natural regulatory T cell depletion in active systemic lupus erythematosus","volume":"175","author":"Miyara","year":"2005","journal-title":"J Immunol"},{"key":"2023090115160836400_kead070-B46","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/ar4245","article-title":"Peripheral regulatory cells immunophenotyping in primary Sjogren's syndrome: a cross-sectional study","volume":"15","author":"Furuzawa-Carballeda","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2023090115160836400_kead070-B47","doi-asserted-by":"crossref","first-page":"854706","DOI":"10.1155\/2015\/854706","article-title":"Distribution of peripheral lymphocyte populations in primary Sjogren's syndrome patients","volume":"2015","author":"Sudzius","year":"2015","journal-title":"J Immunol Res"},{"key":"2023090115160836400_kead070-B48","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3389\/fimmu.2018.01755","article-title":"IL-2 inhibition of Th17 generation rather than induction of treg cells is impaired in primary Sjogren's syndrome patients","volume":"9","author":"Luo","year":"2018","journal-title":"Front Immunol"},{"key":"2023090115160836400_kead070-B49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-022-02769-y","article-title":"Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjogren's syndrome","volume":"24","author":"Keindl","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2023090115160836400_kead070-B50","doi-asserted-by":"crossref","first-page":"626193","DOI":"10.3389\/fimmu.2021.626193","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"2023090115160836400_kead070-B51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023090115160836400_kead070-B52","doi-asserted-by":"crossref","first-page":"102364","DOI":"10.1016\/j.jaut.2019.102364","article-title":"Sjogren's syndrome: old and new therapeutic targets","volume":"110","author":"Mavragani","year":"2020","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4049\/jimmunol.1401118","article-title":"A crucial role of RORgammat in the development of spontaneous Sialadenitis-like Sjogren's syndrome","volume":"194","author":"Iizuka","year":"2015","journal-title":"J Immunol"},{"key":"2023090115160836400_kead070-B54","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"2023090115160836400_kead070-B55","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nn.2747","article-title":"Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse","volume":"14","author":"Yang","year":"2011","journal-title":"Nat Neurosci"},{"key":"2023090115160836400_kead070-B56","doi-asserted-by":"crossref","first-page":"e2241451","DOI":"10.1001\/jamanetworkopen.2022.41451","article-title":"Efficacy and safety of low-dose interleukin 2 for primary Sjogren syndrome: a randomized clinical trial","volume":"5","author":"He","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023090115160836400_kead070-B57","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.3390\/ijms21228733","article-title":"Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary Sjogren's syndrome","volume":"21","author":"Cano-Ortiz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023090115160836400_kead070-B58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1756-185X.13962","article-title":"Interleukin-35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases","volume":"24","author":"Wang","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2023090115160836400_kead070-B59","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1182\/blood-2008-12-195354","article-title":"Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes","volume":"113","author":"Sharma","year":"2009","journal-title":"Blood"},{"key":"2023090115160836400_kead070-B60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"2023090115160836400_kead070-B61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaut.2006.11.003","article-title":"Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice","volume":"27","author":"Sharma","year":"2006","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B62","doi-asserted-by":"crossref","first-page":"13559","DOI":"10.1038\/ncomms13559","article-title":"USP21 prevents the generation of T-helper-1-like Treg cells","volume":"7","author":"Li","year":"2016","journal-title":"Nat Commun"},{"key":"2023090115160836400_kead070-B63","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/eji.200839196","article-title":"Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions","volume":"39","author":"Duarte","year":"2009","journal-title":"Eur J Immunol"},{"key":"2023090115160836400_kead070-B64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","article-title":"Treg cells in autoimmunity: from identification to Treg-based therapies","volume":"41","author":"Goschl","year":"2019","journal-title":"Semin Immunopathol"},{"key":"2023090115160836400_kead070-B65","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41590-022-01244-9","article-title":"Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche","volume":"23","author":"Liu","year":"2022","journal-title":"Nat Immunol"},{"key":"2023090115160836400_kead070-B66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12974-020-02025-7","article-title":"CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis","volume":"17","author":"Naughton","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2023090115160836400_kead070-B67","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2023090115160836400_kead070-B68","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s13238-014-0069-5","article-title":"The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury","volume":"5","author":"Diao","year":"2014","journal-title":"Protein Cell"},{"key":"2023090115160836400_kead070-B69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","article-title":"Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease","volume":"204","author":"Lahl","year":"2007","journal-title":"J Exp Med"},{"key":"2023090115160836400_kead070-B70","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023090115160836400_kead070-B71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/BOR.0000000000000739","article-title":"Cutaneous and systemic connections in lupus","volume":"32","author":"Maz","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2023090115160836400_kead070-B72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol"},{"key":"2023090115160836400_kead070-B73","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"2023090115160836400_kead070-B74","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.175.5.3053","article-title":"Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice","volume":"175","author":"Masteller","year":"2005","journal-title":"J Immunol"},{"key":"2023090115160836400_kead070-B75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cei.12817","article-title":"Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La\/Sjogren's syndrome (SS)-B","volume":"186","author":"Pan","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2023090115160836400_kead070-B76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.autrev.2014.10.011","article-title":"GITR+ regulatory T cells in the treatment of autoimmune diseases","volume":"14","author":"Petrillo","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2023090115160836400_kead070-B77","doi-asserted-by":"crossref","first-page":"104193","DOI":"10.1016\/j.cellimm.2020.104193","article-title":"Regulatory T cell therapy: current and future design perspectives","volume":"356","author":"Rana","year":"2020","journal-title":"Cell Immunol"},{"key":"2023090115160836400_kead070-B78","doi-asserted-by":"crossref","first-page":"102289","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/jci.insight.136185","article-title":"CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD","volume":"5","author":"Imura","year":"2020","journal-title":"JCI Insight"},{"key":"2023090115160836400_kead070-B80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4049\/jimmunol.1401145","article-title":"Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region","volume":"194","author":"Rossetti","year":"2015","journal-title":"J Immunol"},{"key":"2023090115160836400_kead070-B81","doi-asserted-by":"crossref","first-page":"102376","DOI":"10.1016\/j.jaut.2019.102376","article-title":"Treg cells in health and autoimmune diseases: new insights from single cell analysis","volume":"110","author":"Scheinecker","year":"2020","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B82","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/ard.2010.137935","article-title":"The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study","volume":"70","author":"Becker","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023090115160836400_kead070-B83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int Immunol"},{"key":"2023090115160836400_kead070-B84","doi-asserted-by":"crossref","first-page":"i46","DOI":"10.1136\/annrheumdis-2011-200593","article-title":"HDAC inhibitor therapy in autoimmunity and transplantation","volume":"71(Suppl 2)","author":"Hancock","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2023090115160836400_kead070-B85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2016.01.009","article-title":"Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells","volume":"44","author":"Kuswanto","year":"2016","journal-title":"Immunity"},{"key":"2023090115160836400_kead070-B86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2023090115160836400_kead070-B87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023090115160836400_kead070-B88","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015","journal-title":"J Autoimmun"},{"key":"2023090115160836400_kead070-B89","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023090115160836400_kead070-B90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12865-019-0305-0","article-title":"Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17\/Treg cells in refractory SLE patients","volume":"20","author":"Zhao","year":"2019","journal-title":"BMC Immunol"},{"key":"2023090115160836400_kead070-B91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2023090115160836400_kead070-B92","doi-asserted-by":"crossref","first-page":"887354","DOI":"10.3389\/fmed.2022.887354","article-title":"Low dose interleukin-2 ameliorates Sjogren's syndrome in a murine model","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"2023090115160836400_kead070-B93","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/art.42244","article-title":"In vivo generation of SSA\/Ro antigen-specific regulatory T cells improves experimental Sjogren's syndrome in mice","volume":"74","author":"Xu","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2023090115160836400_kead070-B94","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"2023090115160836400_kead070-B95","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.3390\/ijms20194750","article-title":"Mesenchymal stem cells extract (MSCsE)-based therapy alleviates xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome-like disease","volume":"20","author":"Abughanam","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023090115160836400_kead070-B96","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s13287-021-02541-0","article-title":"Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjogren's syndrome by modulating the balance of Treg and Th17 cells","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"2023090115160836400_kead070-B97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-021-02475-1","article-title":"Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjogren's syndrome","volume":"23","author":"Akgul","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2023090115160836400_kead070-B98","doi-asserted-by":"crossref","first-page":"4896727","DOI":"10.1155\/2020\/4896727","article-title":"B7-H4 inhibits the development of primary Sjogren's syndrome by regulating treg differentiation in NOD\/Ltj Mice","volume":"2020","author":"Zheng","year":"2020","journal-title":"J Immunol Res"},{"key":"2023090115160836400_kead070-B99","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.molimm.2022.04.006","article-title":"Sirolimus therapy restores the PD-1+ICOS+Tfh: CD45RA-Foxp3(high) activated Tfr cell balance in primary Sjogren's syndrome","volume":"147","author":"Wang","year":"2022","journal-title":"Mol Immunol"},{"key":"2023090115160836400_kead070-B100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.joim.2021.01.008","article-title":"Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review","volume":"19","author":"Wei","year":"2021","journal-title":"J Integr Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead070\/49334430\/kead070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/9\/2963\/51329261\/kead070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/9\/2963\/51329261\/kead070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:41:20Z","timestamp":1693582880000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/9\/2963\/7039676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":100,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,2,15]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead070","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,2,15]]}}}